Front Street Capital Management, Inc. Pfizer Inc Transaction History

Front Street Capital Management, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $18,238 - $23,690	698 Added 17.45%	4,697 $135,000
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $128,327 - $150,002	3,999 New	3,999 $133,000
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $1,252 - $1,635	-30 Reduced 0.58%	5,126 $2.77 Million
Q3 2022 Nov 09, 2022	SELL	$43.76 - $53.42 $525 - $641	-12 Reduced 0.23%	5,156 $226,000
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $9,836 - $12,188	215 Added 4.34%	5,168 $268,000
Q4 2021 Feb 08, 2022	SELL	$41.32 - $61.25 $743 - $1,102	-18 Reduced 0.36%	4,953 $293,000
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $195,111 - $250,637	4,971 New	4,971 $214,000
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $152,368 - $217,700	-5,637 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $1,723 - $2,090	-50 Reduced 0.88%	5,637 $248,000
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $25,528 - $29,616	-800 Reduced 12.33%	5,687 $202,000
Q3 2017 Nov 13, 2017	SELL	$31.0 - $34.15 $42,718 - $47,058	-1,378 Reduced 17.52%	6,487 $232,000
Q2 2017 Aug 08, 2017	BUY	N/A	7,865	7,865 $264,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Front Street Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Front Street Capital Management, Inc. with notifications on news.